Determination of the relative contribution of three genes - The cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene - To the etiology of idiopathic chronic pancreatitis

European Journal of Human Genetics

Volumn 10, Issue 2, 2002, Pages 100-106

  Audrézet, Marie Pierre ^a   Chen, Jian Min ^b   Le Maréchal, Cedric ^b   Ruszniewski, Philippe ^d   Robaszkiewicz, Michel ^e   Ragueaneas, Odile ^a   Quearea, Isabelle ^a   Scotet, Virginie ^c   Férec, Claude ^a,b,c  

^a BREST UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^d BEAUJON HOSPITAL   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Cationic trypsinogen gene (PRSS1); Cystic fibrosis transmembrane conductance regulator (CFTR); Idiopathic chronic pancreatitis (ICP); Mutation analysis; Pancreatic secretory trypsin inhibitor (PSTI SPINK1; Trans heterozygote

Indexed keywords

APROTININ; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ADULT; ALLELE; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC GAIN; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; IDIOPATHIC DISEASE; INTRON; MALE; PRIORITY JOURNAL; REGULATOR GENE;

CHRONIC DISEASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PANCREATITIS; TRYPSIN; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TRYPSINOGEN;

EID: 85047700382     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200786     Document Type: Article

References (41)

1. Chronic pancreatitis
2. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
3. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
4. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
5. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
6. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis
7. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis
8. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis
9. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis
10. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis
11. Increased prevalence of mutations of the cystic fibrosis gene in idiopathic chronic and recurrent pancreatitis
12. Polyvariant mutant CFTR genes in patients with chronic pancreatitis
13. Is isolated idiopathic pancreatitis associated with CFTR mutations?
14. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis
15. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations
16. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis
17. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis
18. High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay
19. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis
20. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis
21. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis
22. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): Major implications for genetic counselling
23. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease
24. Wanted: A consensus nomenclature for cationic trypsinogen mutations
25. Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens
26. Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) gene
27. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
28. Cystic fibrosis gene mutations and pancreatitis risk: Relation to epithelial ion transport and trypsin inhibitor gene mutations
29. Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis
30. A CGC>CAT gene conversion-like event resulting in the R122H mutation in the cationic trypsinogen gene and its implication in the genotyping of pancreatitis
31. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis
32. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis
33. A combined analysis of the cystic fibrosis transmembrane conductance regulator: Implications for structure and disease models
34. Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel
35. The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel
36. Mutations of the cystic fibrosis gene and pancreatitis
37. Genotype and phenotype in cystic fibrosis
38. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
39. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis
40. Trypsinogen mutations in chronic pancreatitis
41. Genetic risk factors in chronic pancreatitis